Found 126 clinical trials
-
Multi-country trial
-
Phase 3 trial
-
Accepting Seniors
-
Accepting adults
-
100s of participants
-
An interventional trial
-
For all genders
-
Currently Recruiting
The Late Presenter Treatment Optimisation Study
HIV: The Boosted Protease Inhibitor combination (PI) which is a combination tablet containing: darunavir, cobicistat, emtricitabine and tenofovir alafenamide. It was approved for use in Europe
- 120 views
- 23 Jan, 2021
- 29 locations
-
Multi-country trial
-
Phase 2 trial
-
Accepting Seniors
-
Accepting adults
-
100s of participants
-
An interventional trial
-
For all genders
-
Immunology
-
Currently Recruiting
A Dose-Range Finding Clinical Trial Study in Human Immunodeficiency Virus (HIV-1) Infected Treatment-Naive Adults
] or emtricitabine/tenofovir alafenamide [FTC/TAF]), in approximately 240 treatment-nave HIV-1 infected adults. In the experimental arms, GSK3640254 will be administered in 3 blinded doses until the
- 0 views
- 02 Mar, 2021
- 35 locations
-
Phase 2 trial
-
Accepting Seniors
-
Accepting adults
-
1000s of participants
-
An interventional trial
-
For all genders
-
Currently Recruiting
Effectiveness and Safety of Medical Treatment for SARS-CoV-2 (COVID-19) in Colombia
, Emtricitabine/ Tenofovir acting over bacterial co-infection Azithromycin (Azithro), or modifying the inflammatory response of the host (Tocilizumab, colchicine, dexamethasone, Icatibant, ibuprofen lipidic and
- 62 views
- 18 Feb, 2021
- 7 locations
-
Phase 3 trial
-
Accepting Seniors
-
Accepting adults
-
1000s of participants
-
An interventional trial
-
For all genders
-
Currently Recruiting
Tuberculosis Preventive Therapy Among Latent Tuberculosis Infection in HIV-infected Individuals
The investigators want to know if ultra-short, effective treatment for latent tuberculosis (TB) infection (LTBI) could dramatically reduce the global incidence of active TB or not. The investigators hypothesize that short-course (4-week) daily isoniazid/rifapentine (INH/RPT) (1HP) is not inferior to standard -course (12 weeks) INH/RPT weekly regimen (3HP) for the …
- 0 views
- 25 Jan, 2021
- 16 locations
-
Phase 4 trial
-
Accepting pediatric ages
-
Accepting Seniors
-
1000s of participants
-
An interventional trial
-
For all genders
-
Immunology
-
Currently Recruiting
Cessation of Long Term NAs vs. Keeping on NAs Among CHB Patients (CNAVK)
To Identify the collected cases who can stop NAs safely with satisfactory clinical outcome including sustain viral remission and HBsAg clearance among chronic hepatitis B(CHB) patients.
- 0 views
- 01 Mar, 2021
-
Multi-country trial
-
Phase 1 trial
-
Accepting adults
-
10s of participants
-
An interventional trial
-
For all genders
-
Immunology
-
Currently Recruiting
Safety and Virologic Effect of a Human Monoclonal Antibody (VRC01) Administered Intravenously to Adults During Early Acute HIV Infection
This study will evaluate the safety and virologic effect of an experimental human monoclonal antibody (mAb), VRC-HIVMAB060-00-AB (VRC01), alone or in combination with antiretroviral therapy (ART), in adults during early acute HIV infection.
- 19 views
- 24 Jan, 2021
- 5 locations
-
Accepting adults
-
100s of participants
-
An interventional trial
-
For males only
-
Immunology
-
Currently Recruiting
HealthMindr App to Increase Pre-exposure Prophylaxis (PrEP) Uptake and Retention Among Men Who Have Sex With Men (MSM)
This study is a randomized controlled clinical trial of a theoretically based mobile app, HealthMindr, to increase pre-exposure prophylaxis (PrEP) uptake among men who have sex with men (MSM) to prevent human immunodeficiency virus (HIV). Participants in the intervention arm will receive access to the HealthMindr app, with information about …
- 141 views
- 25 Jan, 2021
- 3 locations
-
Phase 3 trial
-
Accepting adults
-
100s of participants
-
An interventional trial
-
For all genders
-
Immunology
-
Currently Recruiting
Pradefovir Treatment for the Patients With Chronic Hepatitis B Virus Infections: a Phase3 Study
This is a phase three study to evaluate the safety and efficacy of Pradefovir treatment in chronic hepatitis B patients. Subject will be randomized to Pradefovir group and TDF group at a ratio of 2:1. Treatment duration will be 96w in randomization and followed by 48w in open. The interim …
- 10 views
- 25 Jan, 2021
- 1 location
-
Multi-country trial
-
Phase 4 trial
-
Accepting Seniors
-
Accepting adults
-
1000s of participants
-
An interventional trial
-
For all genders
-
Immunology
-
Currently Recruiting
Dolutegravir and Darunavir Evaluation in Adults Failing Therapy
DEFT is a randomised, open-label study in HIV-1 infected patients failing first-line antiretroviral therapy (ART). The study compares 2 regimens of second-line ART (dolutegravir and darunavir pharmaco-enhanced with ritonavir and dolutegravir and 2 prespecified NRTIs) with the WHO recommended regimen of 2NRTIs plus a ritonavir-boosted PI (Standard of Care (SOC)). …
- 1172 views
- 28 Feb, 2021
- 32 locations
-
Phase 3 trial
-
Accepting Seniors
-
Accepting adults
-
100s of participants
-
An interventional trial
-
For all genders
-
Hepatology (Liver, Pancreatic, Gall Bladder)
-
Currently Recruiting
Tenofovir to Prevent HBV Reactivation
The purpose of the study is to determine how effective preemptive tenofovir therapy is in preventing the re-activation of Hepatitis B infection, in patients who are receiving rituximab-based
- 16 views
- 23 Jan, 2021
- 2 locations